FDA Form 483

What is FDA Form 483?

When FDA investigators complete an establishment inspection and have observed objectionable conditions, they present the firm's management with a Form 483 listing those observations. The FDA's own Form 483 FAQ is explicit about its status: the 483 records observations; it is not a final agency determination that violations occurred. For device manufacturers, observations most often concern CAPA, complaint handling, design controls, process validation and purchasing controls.

How should a manufacturer respond to a 483?

In writing, quickly, and with evidence. The FDA has stated that responses received within 15 business days will be considered before the agency decides whether further action, such as a Warning Letter, is warranted. Good responses address each observation individually, distinguish the immediate correction from the systemic corrective and preventive action, attach objective evidence, and commit to dated milestones for what remains open.

Is a Form 483 public?

Not automatically, but 483s are obtainable under the Freedom of Information Act and the FDA proactively publishes some inspection information. Business partners and acquirers routinely request recent 483s during due diligence, so the quality of the response record matters commercially as well as regulatorily.

Do foreign device manufacturers receive 483s?

Yes. The FDA inspects foreign establishments that manufacture devices for the U.S. market, and observations at a foreign site carry the same weight as domestic ones — with import alerts among the practical consequences of an unresolved inspection. Manufacturers entering the United States should treat FDA inspection readiness as part of market-entry planning, not a post-launch concern.